Introduction Invasive meningococcal disease (IMD) is uncommon but still causes
considerable public health burden due to its high mortality and morbidity. This review aims …

Meningococcal disease remains an important cause of morbidity and death worldwide
despite the development and increasing implementation of effective vaccines. Elimination of …

Invasive meningococcal disease remains a substantial global public health burden despite
being vaccine-preventable worldwide. More than one million cases are reported annually …

Vaccination of at-risk populations against Neisseria meningitidis is an important strategy to
prevent invasive meningococcal disease (IMD). The objective of this study was to …

Although rare, invasive meningococcal disease remains an important cause of mortality and
morbidity in children and young adults. Vaccines have been successfully introduced to help …

Adolescents have the highest rates of meningococcal carriage and transmission.
Interrupting the adolescent habitat in order to reduce carriage and transmission within …

Background In response to the recent serogroup W invasive meningococcal disease (IMD-
W) epidemic in the Netherlands, meningococcal serogroup C (MenC) conjugate vaccination …

We evaluated the outcome of invasive meningococcal disease in children< 15 years of age
(n= 181). Neisseria meningitidis serogroup B comprised 78% of bacterial isolates. Case …

Abstract New Zealand (Aotearoa) experienced a Neisseria meningitidis serogroup B
epidemic during 1991–2006, and incidence remains twice that of other high-income …

Objective The Fluids in Shock (FiSh) Trial proposes to evaluate whether restrictive fluid
bolus therapy (10 mL/kg) is more beneficial than current recommended practice (20 mL/kg) …